{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:05:08Z","timestamp":1753891508862,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2023.1215560","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T16:32:27Z","timestamp":1695141147000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["New therapeutic hypothesis for infantile extrinsic hydrocephalus"],"prefix":"10.3389","volume":"14","author":[{"given":"Masahiro","family":"Kameda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinaga","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Wanibuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00701-017-3115-2","article-title":"Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials","volume":"159","author":"Kameda","year":"2017","journal-title":"Acta Neurochir."},{"key":"B2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2176\/nmc.st.2020-0292","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus (third edition): endorsed by the Japanese Society of Normal Pressure Hydrocephalus","volume":"61","author":"Nakajima","year":"2021","journal-title":"Neurol Med Chir."},{"key":"B3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1227\/NEU.0000000000000196","article-title":"Ventriculoperitoneal shunt 30-day failure rate: a retrospective international cohort study","volume":"74","author":"Al-Tamimi","year":"2014","journal-title":"Neurosurgery."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2017.8.JNS17399","article-title":"Factors associated with 30-day ventriculoperitoneal shunt failure in pediatric and adult patients","volume":"2018","author":"Anderson","year":"2018","journal-title":"J Neurosurg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/00006123-199808000-00068","article-title":"Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus","volume":"43","author":"Drake","year":"1998","journal-title":"Neurosurgery"},{"key":"B6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000055960","article-title":"Long-term follow-up data from the Shunt Design Trial","volume":"33","author":"Kestle","year":"2000","journal-title":"Pediatr Neurosurg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1227\/neu.0000000000002301","article-title":"Internal ventricular cerebrospinal fluid shunt for adult hydrocephalus: a systematic review and meta-analysis of the infection rate","volume":"2022","author":"Ramasy Razafindratovo","year":"2022","journal-title":"Neurosurgery."},{"key":"B8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3171\/2015.8.PEDS15253","article-title":"A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection","volume":"17","author":"Kestle","year":"2016","journal-title":"J Neurosurg Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.wneu.2011.10.034","article-title":"Ventriculoperitoneal shunt surgery and the risk of shunt infection in patients with hydrocephalus: long-term single institution experience","volume":"78","author":"Reddy","year":"2012","journal-title":"World Neurosurg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3171\/2015.5.PEDS14532","article-title":"Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life","volume":"16","author":"Paulsen","year":"2015","journal-title":"J Neurosurg Pediatr."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/j.wneu.2019.08.167","article-title":"Adult outcome in shunted pediatric hydrocephalus: long-term functional, social, and neurocognitive results","volume":"132","author":"Gmeiner","year":"2019","journal-title":"World Neurosurg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00570260","article-title":"Long-term follow-up in 233 patients with congenital hydrocephalus","volume":"11","author":"Lumenta","year":"1995","journal-title":"Child's Nervous System."},{"key":"B13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3171\/2017.8.PEDS17217","article-title":"Endoscopic third ventriculostomy and choroid plexus cauterization in infant hydrocephalus: a prospective study by the Hydrocephalus Clinical Research Network","volume":"21","author":"Kulkarni","year":"2018","journal-title":"J Neurosurg Pediatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00381-021-05209-5","article-title":"Endoscopic third ventriculostomy and choroid plexus cauterization (ETV\/CPC) for hydrocephalus of infancy: a technical review","volume":"21","author":"Coulter","year":"2021","journal-title":"Child's Nervous System."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s00381-018-3896-5","article-title":"International Infant Hydrocephalus Study (IIHS): 5-year health outcome results of a prospective, multicenter comparison of endoscopic third ventriculostomy (ETV) and shunt for infant hydrocephalus","volume":"34","author":"Kulkarni","year":"2018","journal-title":"Child's Nervous System."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2022.3.PEDS224","article-title":"Endoscopic third ventriculostomy revision after failure of initial endoscopic third ventriculostomy and choroid plexus cauterization","volume":"2022","author":"Arynchyna-Smith","year":"2022","journal-title":"J Neurosurg Pediatr."},{"key":"B17","first-page":"1","article-title":"Hydrocephalus: generalities and clinical presentations","volume-title":"Textbook of Pediatric Neurosurgery","author":"Di Rocco","year":"2019"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1111\/cns.13947","article-title":"Transplantation of modified human bone marrow-derived stromal cells affords therapeutic effects on cerebral ischemia in rats","volume":"28","author":"Kawauchi","year":"2022","journal-title":"CNS Neurosci Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"70789","DOI":"10.3390\/biomedicines9070789","article-title":"Vagus nerve stimulation with mild stimulation intensity exerts anti-inflammatory and neuroprotective effects in Parkinson's disease model rats","volume":"9","author":"Kin","year":"2021","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2633105520959064","DOI":"10.1177\/2633105520959064","article-title":"Encapsulation of mesenchymal stem cells: dissecting the underlying mechanism of mesenchymal stem cell transplantation therapy","volume":"15","author":"Kin","year":"2020","journal-title":"Neurosci Insights."},{"key":"B21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnagi.2020.00164","article-title":"Long-term continuous cervical spinal cord stimulation exerts neuroprotective effects in experimental Parkinson's disease","volume":"12","author":"Kuwahara","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"147ra11","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3978\/j.issn.2224-4336.2014.07.02","article-title":"New concepts in the pathogenesis of hydrocephalus","volume":"3","author":"Krishnamurthy","year":"2014","journal-title":"Transl Pediatr."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: a beginner's guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41583-021-00454-8","article-title":"Molecular mechanisms of brain water transport","volume":"22","author":"MacAulay","year":"2021","journal-title":"Nat Rev Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"104987","DOI":"10.1016\/j.isci.2022.104987","article-title":"The glymphatic system: current understanding and modeling","volume":"25","author":"Bohr","year":"2022","journal-title":"iScience."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1084\/jem.20211275","article-title":"Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration","volume":"219","author":"Ishida","year":"2022","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2648","DOI":"10.1212\/WNL.0000000000201300","article-title":"Association of MRI indices of glymphatic system with amyloid deposition and cognition in mild cognitive impairment and Alzheimer disease","volume":"99","author":"Kamagata","year":"2022","journal-title":"Neurology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.mehy.2018.07.007","article-title":"The putative glymphatic signature of chronic fatigue syndrome: a new view on the disease pathogenesis and therapy","volume":"118","author":"Wostyn","year":"2018","journal-title":"Med Hypotheses."},{"key":"B30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41582-020-0321-y","article-title":"Inflammation in acquired hydrocephalus: pathogenic mechanisms and therapeutic targets","volume":"16","author":"Karimy","year":"2020","journal-title":"Nat Rev Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/jnr.24368","article-title":"Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis","volume":"97","author":"Ohta","year":"2019","journal-title":"J Neurosci Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.expneurol.2014.05.011","article-title":"Long-term hydrocephalus alters the cytoarchitecture of the adult subventricular zone","volume":"261","author":"Campos-Ordonez","year":"2014","journal-title":"Exp Neurol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21513","DOI":"10.3390\/ijms141121513","article-title":"Neuroprotective effects of liraglutide for stroke model of rats","volume":"14","author":"Sato","year":"2013","journal-title":"Int J Mol Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"571258","DOI":"10.3389\/fcell.2020.571258","article-title":"Erythropoietin improves atrophy, bleeding and cognition in the newborn intraventricular hemorrhage","volume":"8","author":"Hierro-Bujalance","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1161\/STROKEAHA.107.483008","article-title":"Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia\/ischemia in rats","volume":"38","author":"Iwai","year":"2007","journal-title":"Stroke"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101102","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1073\/pnas.0601377103","article-title":"Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities","volume":"103","author":"Coleman","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainres.2013.01.042","article-title":"The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease","volume":"1502","author":"Thomas Tayra","year":"2013","journal-title":"Brain Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.pnpbp.2018.07.011","article-title":"Carbamoylated erythropoietin induces a neurotrophic gene profile in neuronal cells","volume":"88","author":"Tiwari","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"743926","DOI":"10.3389\/fphar.2022.743926","article-title":"The effect of erythropoietin and its derivatives on ischemic stroke therapy: a comprehensive review","volume":"13","author":"Ma","year":"2022","journal-title":"Front Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00381-018-3865-z","article-title":"Erythropoietin-mediated activation of aquaporin-4 channel for the treatment of experimental hydrocephalus","volume":"34","author":"Rizwan Siddiqui","year":"2018","journal-title":"Child's Nervous System."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1007\/s12035-016-9798-1","article-title":"Exendin-4 reverses biochemical and functional alterations in the blood-brain and blood-CSF barriers in diabetic rats","volume":"54","author":"Zanotto","year":"2017","journal-title":"Mol Neurobiol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1215560\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T16:32:42Z","timestamp":1695141162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1215560\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":43,"alternative-id":["10.3389\/fneur.2023.1215560"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1215560","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"article-number":"1215560"}}